Goods & Services

Cell culture media, other than for medical or veterinary purposes; microorganism culture media, other than for medical or veterinary purposes; biological preparation for use in cell cultures other than for medical or veterinary use; chemicals used as ingredients for cosmetics; chemicals for industrial purposes; culture fluid for human stem cell as an ingredient for cosmetics manufacturing; stem cells for research and scientific purposes; cell culture media for scientific or research purposes. Cosmetics containing culture fluid for human stem cell; cosmetics; soaps and detergents; dentifrices; perfumery. Stem cells for medical purposes; stem cells for clinical purposes; stem cells for veterinary purposes; diagnostic media for bacteriological cultures; cell culture media for microorganism culture for medical use; cell culture for medical use; pharmaceutical preparations for human use; dietary supplements; dietetic preparations adapted for medical purposes. Storage of stem cell and cells; warehousing services for deposited frozen stem cell and cells; consultancy and information relating to warehousing services for deposited frozen stem cell and cells; warehousing services. Manufacturing of stem cells and cells for others (terms too vague in the opinion of the International Bureau – Rule 13 (2) (b) of the Regulations); cell culture services for others (terms too vague in the opinion of the International Bureau – Rule 13 (2) (b) of the Regulations); stem cell culture as an ingredient for cosmetics (terms too vague in the opinion of the International Bureau – Rule 13 (2) (b) of the Regulations); providing scientific information related to cell culture; cytogenetic examination; testing, examination, research and development in the field of regenerative medicine; testing, examination, research and development in the field of cytology; cell culture services, namely, culture of cells for transplant provided from patients (terms too vague in the opinion of the International Bureau – Rule 13 (2) (b) of the Regulations); testing, examination, research and development of cosmetics; medical laboratory services; research in the field of pharmaceuticals; providing information about medical and scientific research in the field of pharmaceuticals; conducting clinical trials for pharmaceuticals. Stem cell bank services; medical treatment services by using cultured cells; stem cell therapy services; collection and preservation of stem cells for use in regenerative medicine; collection and preservation of human blood; providing medical information in the field of cells; providing medical information related to regenerative medicine; provision of medical information; medical treatment and diagnosis services by using cultured cells for medical and clinical purposes; medical services; providing information and data for medical diagnosis and treatment; medical treatment and diagnosis by regenerative medicine; medical treatment and diagnosis services by cell therapy; medical treatment and consulting services by cell preparations; medical treatment services not limited to stem cells; preservation of human blood as a supply source of stem cells; clinical examination; evaluation of clinical examination; genetic testing for medical purposes; providing medical facilities; health clinic services; providing health information; dietary and nutritional guidance; rental of medical machines and apparatus.

Goods & Services

Apparatus for the regeneration of stem cells for medical purposes, namely, for gene editing, gene collection, and gene production. Refrigerated medical container for storage, transportation and cooling of medicines and pharmaceuticals, namely, frozen storage containers for stem cells. Insurance services, namely, underwriting, issuance and brokerage of stem cell insurance. Custom manufacture and non-custom manufacture of medical devices to order and/or specification of others (term considered too vague by the International Bureau - Rule 13 (2) (b) of the Regulations); biomanufacturing for others, namely, custom manufacturing and non-custom manufacturing of medical and biological materials (term considered too vague by the International Bureau - Rule 13 (2) (b) of the Regulations); custom manufacture and non-custom manufacture of machinery for generating stem cells to order and/or specification of others (term considered too vague by the International Bureau - Rule 13 (2) (b) of the Regulations); biomanufacturing for others, namely, custom manufacturing and non-custom manufacturing of clinical grade cells (term considered too vague by the International Bureau - Rule 13 (2) (b) of the Regulations); stem cell banking in the nature of stem cell freezing services. Scientific and medical research in the field of stem cell, gene research, and gene editing; blood analysis services; medical and scientific research, namely, testing, inspection, and research of stem cells; biological cloning services, namely, organ reproduction services; biological cloning services, namely, dna, rna and protein reproduction services; testing, inspection, and research of cosmetics; collection of biological materials, namely, stem cells for scientific research purposes; medical and scientific research services, namely, research in the field of stem cells and gene diagnostics; dna analysis services for scientific research purposes; drug discovery services; scientific research services, namely, research in the field of regenerative medicine; stem cell and gene expression analysis for scientific research purposes; stem cell and epigenetic state analysis for scientific research purposes; proteomic analysis for scientific research purposes; stem cell and gene collection services for research purposes. Stem cell and gene collection services for medical purposes; medical analysis services for diagnostic and treatment purposes provided by medical laboratories in the nature of stem cell and gene expression analysis; medical analysis services for diagnostic and treatment purposes provided by medical laboratories in the nature of stem cell and epigenetic state analysis; medical analysis services for diagnostic and treatment purposes provided by medical laboratories in the nature of proteomic analysis; healthcare; medical assistance; stem cell therapy and stem cell production services for medical purposes and research purposes (term considered too vague by the International Bureau - Rule 13 (2) (b) of the Regulations); stem cell and gene banking services; cosmetic surgery services; stem cell therapy services, namely, stem cell and gene transplantation services; collection of biological materials, namely, stem cells for medical treatment purposes; medical analysis services for diagnostic and treatment purposes provided by medical laboratories in the nature of stem cell and gene diagnostic services; medical diagnostic and treatment services in the field of regenerative medical services.

Goods & Services

Apparatus for the regeneration of stem cells for medical purposes, namely, for gene editing, gene collection, and gene production. Refrigerated medical container for storage, transportation and cooling of medicines and pharmaceuticals, namely, frozen storage containers for stem cells. Insurance services, namely, underwriting, issuance and brokerage of stem cell insurance. Custom manufacture and non-custom manufacture of medical devices to order and/or specification of others (terms too vague in the opinion of the International Bureau – Rule 13(2)(b) of the Regulations); biomanufacturing for others, namely, custom manufacturing and non-custom manufacturing of medical and biological materials (terms too vague in the opinion of the International Bureau – Rule 13(2)(b) of the Regulations); custom manufacture and non-custom manufacture of machinery for generating stem cells to order and/or specification of others (terms too vague in the opinion of the International Bureau – Rule 13(2)(b) of the Regulations); biomanufacturing for others, namely, custom manufacturing and non-custom manufacturing of clinical grade cells (terms too vague in the opinion of the International Bureau – Rule 13(2)(b) of the Regulations); stem cell banking in the nature of stem cell freezing services. Scientific and medical research in the field of stem cell, gene research, and gene editing; blood analysis services; medical and scientific research, namely, testing, inspection, and research of stem cells; biological cloning services, namely, organ reproduction services; biological cloning services, namely, DNA, RNA and protein reproduction services; testing, inspection, and research of cosmetics; collection of biological materials, namely, stem cells for scientific research purposes; medical and scientific research services, namely, research in the field of stem cells and gene diagnostics; DNA analysis services for scientific research purposes; drug discovery services; scientific research services, namely, research in the field of regenerative medicine; stem cell and gene expression analysis for scientific research purposes; stem cell and epigenetic state analysis for scientific research purposes; proteomic analysis for scientific research purposes. Stem cell and gene collection services for medical purposes and research purposes; medical analysis services for diagnostic and treatment purposes provided by medical laboratories in the nature of stem cell and gene expression analysis; medical analysis services for diagnostic and treatment purposes provided by medical laboratories in the nature of stem cell and epigenetic state analysis; medical analysis services for diagnostic and treatment purposes provided by medical laboratories in the nature of proteomic analysis; healthcare; medical assistance; stem cell therapy and stem cell production services for medical purposes and research purposes (terms too vague in the opinion of the International Bureau – Rule 13(2)(b) of the Regulations); cosmetic surgery services; stem cell therapy services, namely, stem cell and gene transplantation services; collection of biological materials, namely, stem cells for medical treatment purposes; medical analysis services for diagnostic and treatment purposes provided by medical laboratories in the nature of stem cell and gene diagnostic services; medical diagnostic and treatment services in the field of regenerative medical services.

Goods & Services

Apparatus for the regeneration of stem cells for medical purposes, namely, for gene editing, gene collection, and gene production. Refrigerated medical container for storage, transportation and cooling of medicines and pharmaceuticals, namely, frozen storage containers for stem cells. Insurance services, namely, underwriting, issuance and brokerage of stem cell insurance. Custom manufacture and non-custom manufacture of medical devices to order and/or specification of others (terms too vague in the opinion of the International Bureau – Rule 13 2)(b) of the regulations); custom manufacture and non-custom manufacture of medical devices to order and/or specification of others (terms too vague in the opinion of the International Bureau – Rule 13(2)(b) of the regulations); custom manufacture and non-custom manufacture of machinery for generating stem cells to order and/or specification of others (terms too vague in the opinion of the International Bureau – Rule 13(2)(b) of the regulations); biomanufacturing for others, namely, custom manufacturing and non-custom manufacturing of clinical grade cells (terms too vague in the opinion of the International Bureau – Rule 13(2)(b) of the regulations); stem cell banking in the nature of stem cell freezing services. Scientific and medical research in the field of stem cell, gene research, and gene editing; blood analysis services; medical and scientific research, namely, testing, inspection, and research of stem cells; biological cloning services, namely, organ reproduction services; biological cloning services, namely, DNA, RNA and protein reproduction services; testing, inspection, and research of cosmetics; collection of biological materials, namely, stem cells for scientific research purposes; medical and scientific research services, namely, research in the field of stem cells and gene diagnostics; DNA analysis services for scientific research purposes; drug discovery services; scientific research services, namely, research in the field of regenerative medicine; stem cell and gene expression analysis for scientific research purposes; stem cell and epigenetic state analysis for scientific research purposes; proteomic analysis for scientific research purposes. Stem cell and gene collection services for medical purposes and research purposes; medical analysis services for diagnostic and treatment purposes provided by medical laboratories in the nature of stem cell and gene expression analysis; medical analysis services for diagnostic and treatment purposes provided by medical laboratories in the nature of stem cell and epigenetic state analysis; medical analysis services for diagnostic and treatment purposes provided by medical laboratories in the nature of proteomic analysis; healthcare; medical assistance; stem cell therapy and stem cell production services for medical purposes and research purposes (terms too vague in the opinion of the International Bureau – Rule 13(2)(b) of the regulations); cosmetic surgery services; stem cell therapy services, namely, stem cell and gene transplantation services; collection of biological materials, namely, stem cells for medical treatment purposes; medical analysis services for diagnostic and treatment purposes provided by medical laboratories in the nature of stem cell and gene diagnostic services; medical diagnostic and treatment services in the field of regenerative medical services.